Antimicrobial resistance profile of Pseudomonas aeruginosa clinical isolates from healthcare-associated infections in Ethiopia: A systematic review and meta-analysis
Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly h...
Saved in:
| Published in | PloS one Vol. 19; no. 8; p. e0308946 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
13.08.2024
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0308946 |
Cover
| Abstract | Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P. aeruginosa, is necessary for the management of infections based on local information.
This systematic review and meta-analysis aimed to determine the country-wide AMR of P. aeruginosa.
Systematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31st December 2023. Twenty-three studies that provided important data on AMR in P. aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P. aeruginosa AMR profile from healthcare-associated infections. AMR of P. aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen's kappa was computed to determine the agreement between reviewers, the Inverse of variance (I2) was used to evaluate heterogeneity across studies, and Egger's test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication.
This systematic review and meta-analysis revealed that the pooled prevalence of P. aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00-5.76). The pooled prevalence of AMR in P. aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2-35.8) for amikacin to 98.72% (95%CI: 96.39-101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P. aeruginosa was 80.5% (95%CI: 66.25-93.84). Upon subgroup analysis by infection types and year of publication, P. aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018-2020 (73.96%), while comparatively lower during 2021-2023 (42.69%) and 2015-2017 (29.82%).
Significantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections.
This systematic review and meta-analysis was registered on PROSPERO (Registration ID: CRD42024518145). |
|---|---|
| AbstractList | BackgroundAntimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P. aeruginosa, is necessary for the management of infections based on local information.ObjectiveThis systematic review and meta-analysis aimed to determine the country-wide AMR of P. aeruginosa.MethodsSystematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31st December 2023. Twenty-three studies that provided important data on AMR in P. aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P. aeruginosa AMR profile from healthcare-associated infections. AMR of P. aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen's kappa was computed to determine the agreement between reviewers, the Inverse of variance (I2) was used to evaluate heterogeneity across studies, and Egger's test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication.ResultsThis systematic review and meta-analysis revealed that the pooled prevalence of P. aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00-5.76). The pooled prevalence of AMR in P. aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2-35.8) for amikacin to 98.72% (95%CI: 96.39-101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P. aeruginosa was 80.5% (95%CI: 66.25-93.84). Upon subgroup analysis by infection types and year of publication, P. aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018-2020 (73.96%), while comparatively lower during 2021-2023 (42.69%) and 2015-2017 (29.82%).ConclusionsSignificantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections.Protocol registrationThis systematic review and meta-analysis was registered on PROSPERO (Registration ID: CRD42024518145). Background Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P. aeruginosa, is necessary for the management of infections based on local information. Objective This systematic review and meta-analysis aimed to determine the country-wide AMR of P. aeruginosa. Methods Systematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31.sup.st December 2023. Twenty-three studies that provided important data on AMR in P. aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P. aeruginosa AMR profile from healthcare-associated infections. AMR of P. aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen's kappa was computed to determine the agreement between reviewers, the Inverse of variance (I.sup.2) was used to evaluate heterogeneity across studies, and Egger's test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication. Results This systematic review and meta-analysis revealed that the pooled prevalence of P. aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00-5.76). The pooled prevalence of AMR in P. aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2-35.8) for amikacin to 98.72% (95%CI: 96.39-101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P. aeruginosa was 80.5% (95%CI: 66.25-93.84). Upon subgroup analysis by infection types and year of publication, P. aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018-2020 (73.96%), while comparatively lower during 2021-2023 (42.69%) and 2015-2017 (29.82%) Conclusions Significantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections. Protocol registration This systematic review and meta-analysis was registered on PROSPERO (Registration ID: CRD42024518145). Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P. aeruginosa, is necessary for the management of infections based on local information. This systematic review and meta-analysis aimed to determine the country-wide AMR of P. aeruginosa. Systematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31.sup.st December 2023. Twenty-three studies that provided important data on AMR in P. aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P. aeruginosa AMR profile from healthcare-associated infections. AMR of P. aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen's kappa was computed to determine the agreement between reviewers, the Inverse of variance (I.sup.2) was used to evaluate heterogeneity across studies, and Egger's test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication. This systematic review and meta-analysis revealed that the pooled prevalence of P. aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00-5.76). The pooled prevalence of AMR in P. aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2-35.8) for amikacin to 98.72% (95%CI: 96.39-101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P. aeruginosa was 80.5% (95%CI: 66.25-93.84). Upon subgroup analysis by infection types and year of publication, P. aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018-2020 (73.96%), while comparatively lower during 2021-2023 (42.69%) and 2015-2017 (29.82%) Significantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections. Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P. aeruginosa, is necessary for the management of infections based on local information. This systematic review and meta-analysis aimed to determine the country-wide AMR of P. aeruginosa. Systematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31st December 2023. Twenty-three studies that provided important data on AMR in P. aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P. aeruginosa AMR profile from healthcare-associated infections. AMR of P. aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen's kappa was computed to determine the agreement between reviewers, the Inverse of variance (I2) was used to evaluate heterogeneity across studies, and Egger's test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication. This systematic review and meta-analysis revealed that the pooled prevalence of P. aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00-5.76). The pooled prevalence of AMR in P. aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2-35.8) for amikacin to 98.72% (95%CI: 96.39-101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P. aeruginosa was 80.5% (95%CI: 66.25-93.84). Upon subgroup analysis by infection types and year of publication, P. aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018-2020 (73.96%), while comparatively lower during 2021-2023 (42.69%) and 2015-2017 (29.82%). Significantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections. This systematic review and meta-analysis was registered on PROSPERO (Registration ID: CRD42024518145). Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P. aeruginosa, is necessary for the management of infections based on local information.BACKGROUNDAntimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P. aeruginosa, is necessary for the management of infections based on local information.This systematic review and meta-analysis aimed to determine the country-wide AMR of P. aeruginosa.OBJECTIVEThis systematic review and meta-analysis aimed to determine the country-wide AMR of P. aeruginosa.Systematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31st December 2023. Twenty-three studies that provided important data on AMR in P. aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P. aeruginosa AMR profile from healthcare-associated infections. AMR of P. aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen's kappa was computed to determine the agreement between reviewers, the Inverse of variance (I2) was used to evaluate heterogeneity across studies, and Egger's test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication.METHODSSystematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31st December 2023. Twenty-three studies that provided important data on AMR in P. aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P. aeruginosa AMR profile from healthcare-associated infections. AMR of P. aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen's kappa was computed to determine the agreement between reviewers, the Inverse of variance (I2) was used to evaluate heterogeneity across studies, and Egger's test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication.This systematic review and meta-analysis revealed that the pooled prevalence of P. aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00-5.76). The pooled prevalence of AMR in P. aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2-35.8) for amikacin to 98.72% (95%CI: 96.39-101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P. aeruginosa was 80.5% (95%CI: 66.25-93.84). Upon subgroup analysis by infection types and year of publication, P. aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018-2020 (73.96%), while comparatively lower during 2021-2023 (42.69%) and 2015-2017 (29.82%).RESULTSThis systematic review and meta-analysis revealed that the pooled prevalence of P. aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00-5.76). The pooled prevalence of AMR in P. aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2-35.8) for amikacin to 98.72% (95%CI: 96.39-101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P. aeruginosa was 80.5% (95%CI: 66.25-93.84). Upon subgroup analysis by infection types and year of publication, P. aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018-2020 (73.96%), while comparatively lower during 2021-2023 (42.69%) and 2015-2017 (29.82%).Significantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections.CONCLUSIONSSignificantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections.This systematic review and meta-analysis was registered on PROSPERO (Registration ID: CRD42024518145).PROTOCOL REGISTRATIONThis systematic review and meta-analysis was registered on PROSPERO (Registration ID: CRD42024518145). Background Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa , the leading infectious agent in the healthcare setting is now one of the major threats due to AMR. A comprehensive understanding of the magnitude of AMR, particularly highly public health important pathogens such as P . aeruginosa , is necessary for the management of infections based on local information. Objective This systematic review and meta-analysis aimed to determine the country-wide AMR of P . aeruginosa . Methods Systematic searches were performed to retrieve articles from PubMed, Scopus, Web of Science, ScienceDirect electronic databases, Google Scholar search engine, and repository registrars from 2015 to 31 st December 2023. Twenty-three studies that provided important data on AMR in P . aeruginosa were systematically reviewed and analyzed to determine the country-wide magnitude of P . aeruginosa AMR profile from healthcare-associated infections. AMR of P . aeruginosa to 10 different antibiotics were extracted separately into Microsoft Excel and analyzed using STATA 17.0. Cohen’s kappa was computed to determine the agreement between reviewers, the Inverse of variance (I 2 ) was used to evaluate heterogeneity across studies, and Egger’s test to identify publication bias. A random effect model was used to determine the pooled resistance to each antibiotic. Subgroup analysis was performed by infection type and year of publication. Results This systematic review and meta-analysis revealed that the pooled prevalence of P . aeruginosa in clinical specimens associated with HAI was 4.38%(95%CI: 3.00–5.76). The pooled prevalence of AMR in P . aeruginosa for different antibiotics varies, ranging from 20.9% (95%CI: 6.2–35.8) for amikacin to 98.72% (95%CI: 96.39–101.4) for ceftriaxone. The pooled resistance was higher for ceftriaxone (98.72%), Trimethoprim-sulfamethoxazole (75.41), and amoxicillin-clavulanic acid (91.2). In contrast relatively lower AMR were observed for amikacin (20.9%) and meropenem (28.64%). The pooled multi-drug resistance (MDR) in P . aeruginosa was 80.5% (95%CI: 66.25–93.84). Upon subgroup analysis by infection types and year of publication, P . aeruginosa isolated from healthcare-associated infections exhibited higher resistance to ceftazidime (94.72%) compared to isolates from mixed types of healthcare-associated infections (70.84%) and surgical site infections (57.84%). Antimicrobial resistance in gentamicin was higher during the periods of 2018–2020 (73.96%), while comparatively lower during 2021–2023 (42.69%) and 2015–2017 (29.82%) Conclusions Significantly high AMR and MDR were observed from this systematic review and meta-analysis. AMR obtained from this systematic review and meta-analysis urges the need for improved infection control, antimicrobial stewardship practices, and strengthened surveillance systems to control the spread of AMR and ensure effective treatment of P. aeruginosa infections. Protocol registration This systematic review and meta-analysis was registered on PROSPERO (Registration ID: CRD42024518145). |
| Audience | Academic |
| Author | Kumie, Getinet Nigatie, Marye Jemal, Abdu Gashaw, Muluken Tamrat, Ephrem Abate, Biruk Beletew Gedfie, Solomon Reta, Melese Abate Kassa, Mulat Awoke Asmare, Zelalem Getachew, Ermias Gashaw, Yalewayker Ayana, Sisay Dejazmach, Zelalem Abebe, Wagaw Kidie, Atitegeb Abera Sisay, Assefa Misganaw, Tadesse Ashagre, Agenagnew Kassahun, Woldeteklehaymanot Tadesse, Selamyhun |
| AuthorAffiliation | 3 Department of Public Health, College of Health Sciences, Woldia University, Woldia, Ethiopia Nova Southeastern University, UNITED STATES OF AMERICA 1 Department of Medical Laboratory Science, College of Health Sciences, Woldia University, Woldia, Ethiopia 2 Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa 4 Department of Nursing, College of Health Sciences, Woldia University, Woldia, Ethiopia |
| AuthorAffiliation_xml | – name: 3 Department of Public Health, College of Health Sciences, Woldia University, Woldia, Ethiopia – name: Nova Southeastern University, UNITED STATES OF AMERICA – name: 4 Department of Nursing, College of Health Sciences, Woldia University, Woldia, Ethiopia – name: 2 Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa – name: 1 Department of Medical Laboratory Science, College of Health Sciences, Woldia University, Woldia, Ethiopia |
| Author_xml | – sequence: 1 givenname: Zelalem orcidid: 0009-0008-8076-0179 surname: Asmare fullname: Asmare, Zelalem – sequence: 2 givenname: Melese Abate orcidid: 0000-0003-1301-4746 surname: Reta fullname: Reta, Melese Abate – sequence: 3 givenname: Yalewayker surname: Gashaw fullname: Gashaw, Yalewayker – sequence: 4 givenname: Ermias surname: Getachew fullname: Getachew, Ermias – sequence: 5 givenname: Assefa surname: Sisay fullname: Sisay, Assefa – sequence: 6 givenname: Muluken surname: Gashaw fullname: Gashaw, Muluken – sequence: 7 givenname: Ephrem surname: Tamrat fullname: Tamrat, Ephrem – sequence: 8 givenname: Atitegeb Abera surname: Kidie fullname: Kidie, Atitegeb Abera – sequence: 9 givenname: Wagaw surname: Abebe fullname: Abebe, Wagaw – sequence: 10 givenname: Tadesse orcidid: 0000-0001-7994-3797 surname: Misganaw fullname: Misganaw, Tadesse – sequence: 11 givenname: Agenagnew surname: Ashagre fullname: Ashagre, Agenagnew – sequence: 12 givenname: Zelalem surname: Dejazmach fullname: Dejazmach, Zelalem – sequence: 13 givenname: Getinet surname: Kumie fullname: Kumie, Getinet – sequence: 14 givenname: Marye surname: Nigatie fullname: Nigatie, Marye – sequence: 15 givenname: Sisay surname: Ayana fullname: Ayana, Sisay – sequence: 16 givenname: Abdu surname: Jemal fullname: Jemal, Abdu – sequence: 17 givenname: Solomon surname: Gedfie fullname: Gedfie, Solomon – sequence: 18 givenname: Woldeteklehaymanot surname: Kassahun fullname: Kassahun, Woldeteklehaymanot – sequence: 19 givenname: Mulat Awoke surname: Kassa fullname: Kassa, Mulat Awoke – sequence: 20 givenname: Selamyhun surname: Tadesse fullname: Tadesse, Selamyhun – sequence: 21 givenname: Biruk Beletew surname: Abate fullname: Abate, Biruk Beletew |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39137234$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk21rFDEQxxep2Af9BqIBQfTFnclmH_tGjlL1oFDx6W2Yzc7epewm1yRb7QfyezrXu0qvFJF9sSH5_f-TmcwcJnvWWUyS54JPhSzFuws3egv9dEXbUy55VWfFo-RA1DKdFCmXe3fW-8lhCBec57IqiifJvqzJIpXZQfJ7ZqMZjPauMdAzj8GECFYjW3nXmR6Z69jngGPrBmchMEA_Lox1AZjujTWaVCa4HiIG1nk3sCVCH5caPE4gBKcNHbXM2A51NM4GWrLTuDRuZeCYzVi4DhEHiEZT-CuDPxnYlg0YYQKU4DXd6GnyuIM-4LPt_yj5_uH028mnydn5x_nJ7Gyii1rGSYZ1Kriucp5paCSvMy2xLTETeaNzbLqqzUGksqizistWCC5aLaqGN1mei1bKo-TlxnfVu6C2FQ6KnNIyryqZEzHfEK2DC7XyZgB_rRwYdbPh_EKBp1R6VGUldd2WUFDQTJa8qXVWdMjTogYADuT1fhttbAZsNdrood8x3T2xZqkW7koJIVORFyU5vNk6eHc5YohqMEFj34NFN24uTi9eCk7oq3vow-ltqQVQBvRmjgLrtamaVTwrKlGXa2r6AEVfi9RK1I_rxtkVvN0REBPxV1zAGIKaf_3y_-z5j1329R1203jUi-NNn-2CL-6W-m-NbweBgOMNQJMQgsdOaRNh7UOpmV4JrtZTd1s0tZ46tZ06Emf3xLf-_5T9AUwcNF0 |
| CitedBy_id | crossref_primary_10_1016_j_soh_2024_100099 crossref_primary_10_1186_s12879_024_10359_3 crossref_primary_10_1093_lambio_ovaf028 crossref_primary_10_3389_fcimb_2024_1519737 |
| Cites_doi | 10.4103/0974-777X.192962 10.1371/journal.pone.0265102 10.1186/s13104-015-1497-x 10.2147/IDR.S376622 10.1016/S0140-6736(21)02724-0 10.1017/ice.2018.60 10.1016/j.tim.2011.04.005 10.1155/2018/2127814 10.1002/sim.1761 10.1186/s12941-023-00643-6 10.1016/j.jgar.2019.01.032 10.1186/s12879-020-4811-8 10.4103/jgid.jgid_113_17 10.1111/j.1469-0691.2011.03570.x 10.1017/S0950268821001254 10.2147/IDR.S357704 10.1080/14787210.2021.1951705 10.1007/s00248-011-9844-5 10.1186/s13756-017-0222-z 10.9734/IJTDH/2016/27253 10.1371/journal.pone.0257272 10.1186/s13756-018-0431-0 10.1186/s13756-018-0370-9 10.1155/2016/2418902 10.7758/9781610448864.23 10.3390/tropicalmed7030042 10.1179/2047773215Y.0000000030 10.1016/S2214-109X(23)00539-9 10.2147/IDR.S358116 10.1186/s43094-021-00255-x 10.1155/2021/5553356 10.1093/jac/dkz147 10.1016/j.ijid.2016.06.014 10.1596/26707 10.1186/s13756-024-01368-7 10.1186/s12941-021-00440-z |
| ContentType | Journal Article |
| Copyright | Copyright: © 2024 Asmare et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2024 Public Library of Science 2024 Asmare et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 Asmare et al 2024 Asmare et al 2024 Asmare et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: Copyright: © 2024 Asmare et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2024 Public Library of Science – notice: 2024 Asmare et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 Asmare et al 2024 Asmare et al – notice: 2024 Asmare et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0308946 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Public Health |
| DocumentTitleAlternate | Antimicrobial resistance profile of P. aeruginosa in Ethiopia |
| EISSN | 1932-6203 |
| ExternalDocumentID | 3092758835 oai_doaj_org_article_783c9d7a6d5a4370b9c46fe0269aaa0a PMC11321567 A804681975 39137234 10_1371_journal_pone_0308946 |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GeographicLocations | Ethiopia Somalia Iran China Nepal United States--US |
| GeographicLocations_xml | – name: Ethiopia – name: China – name: Iran – name: Somalia – name: Nepal – name: United States--US |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB RIG BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM |
| ID | FETCH-LOGICAL-c693t-4e9210c8504cab3094c3ed7e415bc5ebf8d5a123694803d1101dc18b0b4551d33 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Wed Aug 13 01:17:36 EDT 2025 Wed Aug 27 01:32:01 EDT 2025 Thu Aug 21 18:31:50 EDT 2025 Fri Sep 05 07:22:25 EDT 2025 Fri Jul 25 11:23:46 EDT 2025 Tue Jun 17 22:04:04 EDT 2025 Tue Jun 10 21:04:35 EDT 2025 Fri Jun 27 06:04:30 EDT 2025 Fri Jun 27 05:34:49 EDT 2025 Thu May 22 21:23:57 EDT 2025 Mon Jul 21 06:02:41 EDT 2025 Tue Jul 01 03:55:11 EDT 2025 Thu Apr 24 23:06:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| License | Copyright: © 2024 Asmare et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c693t-4e9210c8504cab3094c3ed7e415bc5ebf8d5a123694803d1101dc18b0b4551d33 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Competing Interests: The authors have declared that no competing interests exist. |
| ORCID | 0000-0003-1301-4746 0009-0008-8076-0179 0000-0001-7994-3797 |
| OpenAccessLink | https://doaj.org/article/783c9d7a6d5a4370b9c46fe0269aaa0a |
| PMID | 39137234 |
| PQID | 3092758835 |
| PQPubID | 1436336 |
| PageCount | e0308946 |
| ParticipantIDs | plos_journals_3092758835 doaj_primary_oai_doaj_org_article_783c9d7a6d5a4370b9c46fe0269aaa0a pubmedcentral_primary_oai_pubmedcentral_nih_gov_11321567 proquest_miscellaneous_3092866710 proquest_journals_3092758835 gale_infotracmisc_A804681975 gale_infotracacademiconefile_A804681975 gale_incontextgauss_ISR_A804681975 gale_incontextgauss_IOV_A804681975 gale_healthsolutions_A804681975 pubmed_primary_39137234 crossref_citationtrail_10_1371_journal_pone_0308946 crossref_primary_10_1371_journal_pone_0308946 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-13 |
| PublicationDateYYYYMMDD | 2024-08-13 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-13 day: 13 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2024 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | Netsanet Awoke (pone.0308946.ref028) 2019; 14 Q Chen (pone.0308946.ref052) 2021; 149 J Gill (pone.0308946.ref045) 2016; 8 E del Barrio-Tofiño (pone.0308946.ref051) 2019; 74 H Motbainor (pone.0308946.ref015) 2020; 20 TM Melaku (pone.0308946.ref014) 2023; 2 H Bizuayehu (pone.0308946.ref029) 2022; 17 G Raman (pone.0308946.ref053) 2018; 7 C Ding (pone.0308946.ref043) 2016; 49 MJ Page (pone.0308946.ref016) 2021; 372 M Masoudifar (pone.0308946.ref050) 2021; 62 WHO (pone.0308946.ref008) 2023 AH Mohamed (pone.0308946.ref044) 2022; 7 T Gebissa (pone.0308946.ref031) 2021; 7 WHO (pone.0308946.ref007) 2015 M. Tilahun (pone.0308946.ref035) 2022; 15 T Alemayehu (pone.0308946.ref024) 2019; 58 Z Asmare (pone.0308946.ref026) 2024; 13 AB Mahmoud (pone.0308946.ref040) 2013; 13 S Worku (pone.0308946.ref038) 2023; 22 W Dessie (pone.0308946.ref012) 2016; 2016 H Mekonnen (pone.0308946.ref032) 2021; 16 S.K Remold (pone.0308946.ref002) 2011; 62 A-P Magiorakos (pone.0308946.ref020) 2012; 18 WHO (pone.0308946.ref009) 2017 T Sahile (pone.0308946.ref034) 2016; 17 B Sartorius (pone.0308946.ref005) 2024; 12 A Acar (pone.0308946.ref041) 2019; 18 B Adugna (pone.0308946.ref023) 2021; 2021 S Abosse (pone.0308946.ref022) 2021; 31 M Abayneh (pone.0308946.ref021) 2022; 15 H Vaez (pone.0308946.ref049) 2018; 10 Shugang Qin (pone.0308946.ref003) 2022; 7 G Sulis (pone.0308946.ref048) 2022; 20 E.B. Breidenstein (pone.0308946.ref010) 2011; 19 M Tolera (pone.0308946.ref037) 2018; 2018 J. Sweeting M (pone.0308946.ref019) 2004; 23 Dagninet Alelign (pone.0308946.ref030) 2022; 15 M Gashaw (pone.0308946.ref013) 2018; 7 Z Munn (pone.0308946.ref017) 2020 CJ Murray (pone.0308946.ref004) 2022; 399 F Prestinaci (pone.0308946.ref047) 2015; 109 G Misha (pone.0308946.ref033) 2021; 20 L Paitoonpong (pone.0308946.ref001) 2013 T Bekele (pone.0308946.ref011) 2015; 8 S Lakoh (pone.0308946.ref025) 2023 NP Parajuli (pone.0308946.ref046) 2017; 6 J Wang (pone.0308946.ref039) 2018; 39 M Tilahun (pone.0308946.ref036) 2022; 15 Y Yang (pone.0308946.ref042) 2023 World_Bank (pone.0308946.ref006) 2017 G Asres (pone.0308946.ref027) 2017; 9 M Borenstein (pone.0308946.ref018) 2019; 3 |
| References_xml | – volume: 8 start-page: 155 issue: 4 year: 2016 ident: pone.0308946.ref045 article-title: Prevalence of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a tertiary level intensive care unit publication-title: Journal of global infectious diseases doi: 10.4103/0974-777X.192962 – volume: 17 start-page: e0265102 issue: 3 year: 2022 ident: pone.0308946.ref029 article-title: Catheter-associated urinary tract infections in adult intensive care units at a selected tertiary hospital, Addis Ababa, Ethiopia. publication-title: Plos one doi: 10.1371/journal.pone.0265102 – volume: 8 start-page: 1 issue: 1 year: 2015 ident: pone.0308946.ref011 article-title: Pseudomonas aeruginosa isolates and their antimicrobial susceptibility pattern among catheterized patients at Jimma University Teaching Hospital, Jimma, Ethiopia. publication-title: BMC Res Notes doi: 10.1186/s13104-015-1497-x – volume: 15 start-page: 3949 year: 2022 ident: pone.0308946.ref035 article-title: Multi-Drug Resistance Profile, Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Gram Negative Bacilli Among Admitted Patients After Surgery with Suspected of Surgical Site Nosocomial Infection North East Ethiopia. publication-title: Infection and Drug Resistance doi: 10.2147/IDR.S376622 – volume: 399 start-page: 629 issue: 10325 year: 2022 ident: pone.0308946.ref004 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: The Lancet doi: 10.1016/S0140-6736(21)02724-0 – volume: 15 start-page: 2427 year: 2022 ident: pone.0308946.ref030 article-title: Bacteriological Profiles, Antimicrobial Susceptibility Patterns, and Associated Factors in Patients Undergoing Orthopedic Surgery with Suspicion of Surgical Site Infection at Arba Minch General Hospital in Southern Ethiopia. publication-title: Int J Microbiol – volume: 39 start-page: 701 issue: 6 year: 2018 ident: pone.0308946.ref039 article-title: The prevalence of healthcare-associated infections in mainland China: a systematic review and meta-analysis. publication-title: infection control & hospital epidemiology. doi: 10.1017/ice.2018.60 – volume: 19 start-page: 419 year: 2011 ident: pone.0308946.ref010 article-title: Pseudomonas aeruginosa: all roads lead to resistance publication-title: Trends Microbiol doi: 10.1016/j.tim.2011.04.005 – volume: 2018 year: 2018 ident: pone.0308946.ref037 article-title: Bacterial Nosocomial Infections and Antimicrobial Susceptibility Pattern among Patients Admitted at Hiwot Fana Specialized University Hospital, Eastern Ethiopia. publication-title: Advances in Medicine. doi: 10.1155/2018/2127814 – year: 2023 ident: pone.0308946.ref008 publication-title: Antimicrobial resistance – volume: 23 start-page: 1351 issue: 9 year: 2004 ident: pone.0308946.ref019 article-title: What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data. publication-title: Statistics in medicine. doi: 10.1002/sim.1761 – volume-title: JBI Manual for Evidence Synthesis year: 2020 ident: pone.0308946.ref017 – volume: 22 start-page: 96 issue: 1 year: 2023 ident: pone.0308946.ref038 article-title: Bacterial profile of surgical site infection and antimicrobial resistance patterns in Ethiopia: a multicentre prospective cross-sectional study publication-title: Annals of Clinical Microbiology and Antimicrobials doi: 10.1186/s12941-023-00643-6 – volume: 18 start-page: 64 year: 2019 ident: pone.0308946.ref041 article-title: Pooled prevalence and trends of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates over the past 10 years in Turkey: A meta-analysis publication-title: Journal of Global Antimicrobial Resistance doi: 10.1016/j.jgar.2019.01.032 – volume: 31 issue: 3 year: 2021 ident: pone.0308946.ref022 article-title: Antimicrobial Resistance Profile of Bacterial Isolates Identified from Surgical Site Infections at a Referral Hospital, Northwest Ethiopia. publication-title: Ethiopian Journal of Health Sciences – volume: 20 start-page: 1 year: 2020 ident: pone.0308946.ref015 article-title: Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. publication-title: BMC infectious diseases. doi: 10.1186/s12879-020-4811-8 – volume: 10 start-page: 212 issue: 4 year: 2018 ident: pone.0308946.ref049 article-title: Multidrug resistant Pseudomonas aeruginosa in Iran: A systematic review and metaanalysis publication-title: Journal of global infectious diseases doi: 10.4103/jgid.jgid_113_17 – volume: 2 issue: 3 year: 2023 ident: pone.0308946.ref014 article-title: Antibiotics Resistance Pattern of Aerobic Bacteria Causing Surgical Site Wound Infection and its Associated Factors in Public Hospital, Dire Dawa-Eastern Ethiopia publication-title: International Journal of Clinical Infectious Diseases – volume: 18 start-page: 268 issue: 3 year: 2012 ident: pone.0308946.ref020 article-title: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2011.03570.x – volume: 149 year: 2021 ident: pone.0308946.ref052 article-title: Risk factors for antibiotic resistance development in healthcare settings in China: a systematic review. publication-title: Epidemiology & Infection doi: 10.1017/S0950268821001254 – volume: 7 issue: 199 year: 2022 ident: pone.0308946.ref003 article-title: Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics publication-title: Signal Transduction and Targeted Therapy – volume: 9 start-page: 12 issue: 4 year: 2017 ident: pone.0308946.ref027 article-title: Prevalence of multidrug resistant Bacteria in postoperative wound infections at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. publication-title: Arch Med – year: 2017 ident: pone.0308946.ref009 publication-title: Global priority list of antibiotic-resistant bacteria – volume: 15 start-page: 1807 year: 2022 ident: pone.0308946.ref021 article-title: Assessment of Bacterial Profiles and Antimicrobial Susceptibility Pattern of Isolates Among Patients Diagnosed with Surgical Site Infections at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia: A Prospective Observational Cohort Study. publication-title: Infection and Drug Resistance. doi: 10.2147/IDR.S357704 – volume: 20 start-page: 147 issue: 2 year: 2022 ident: pone.0308946.ref048 article-title: Antimicrobial resistance in low-and middle-income countries: current status and future directions. publication-title: Expert review of anti-infective therapy. doi: 10.1080/14787210.2021.1951705 – volume: 62 start-page: 505 year: 2011 ident: pone.0308946.ref002 article-title: Differential habitat use and niche partitioning by Pseudomonas species in human homes publication-title: Microb Ecol doi: 10.1007/s00248-011-9844-5 – volume: 6 start-page: 1 issue: 1 year: 2017 ident: pone.0308946.ref046 article-title: High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. publication-title: Antimicrobial Resistance & Infection Control. doi: 10.1186/s13756-017-0222-z – volume: 17 start-page: 1 issue: 4 year: 2016 ident: pone.0308946.ref034 article-title: Post-surgical infection and antibiotic susceptibility patterns of bacteria isolated from admitted patients with signs of infection at Jimma University specialized hospital, Jimma, Ethiopia publication-title: International Journal of TROPICAL DISEASE & Health. doi: 10.9734/IJTDH/2016/27253 – volume: 58 year: 2019 ident: pone.0308946.ref024 article-title: High burden of Nosocomial infections caused by multi-drug Re-sistant pathogens in pediatric patients at Hawassa university comprehensive specialized hospital publication-title: Ethiopian Medical Journal – year: 2015 ident: pone.0308946.ref007 publication-title: Global action plan on antimicrobial resistance – volume: 16 start-page: e0257272 issue: 11 year: 2021 ident: pone.0308946.ref032 article-title: Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study. publication-title: PLoS One. doi: 10.1371/journal.pone.0257272 – volume: 7 start-page: 1 year: 2018 ident: pone.0308946.ref013 article-title: Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study. publication-title: Antimicrobial Resistance & Infection Control. doi: 10.1186/s13756-018-0431-0 – volume: 7 start-page: 1 year: 2018 ident: pone.0308946.ref053 article-title: Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. publication-title: Antimicrobial Resistance & Infection Control. doi: 10.1186/s13756-018-0370-9 – volume: 62 start-page: E943 issue: 4 year: 2021 ident: pone.0308946.ref050 article-title: Health care-associated infections, including device-associated infections, and antimicrobial resistance in Iran: The national update for 2018 publication-title: Journal of Preventive Medicine and Hygiene – volume: 13 start-page: 165 year: 2013 ident: pone.0308946.ref040 article-title: Prevalence of multidrug-resistant Pseudomonas aeruginosa in patients with nosocomial infections at a university hospital in Egypt, with special reference to typing methods publication-title: J Virol Microbiol – volume: 2016 year: 2016 ident: pone.0308946.ref012 article-title: Pattern of bacterial pathogens and their susceptibility isolated from surgical site infections at selected referral hospitals, Addis Ababa, Ethiopia. publication-title: International journal of microbiology doi: 10.1155/2016/2418902 – volume: 3 start-page: 453 year: 2019 ident: pone.0308946.ref018 article-title: Heterogeneity in meta-analysis. publication-title: The handbook of research synthesis and meta-analysis. doi: 10.7758/9781610448864.23 – volume: 372 start-page: n71 year: 2021 ident: pone.0308946.ref016 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ (Clinical research ed). – volume: 7 start-page: 42 issue: 3 year: 2022 ident: pone.0308946.ref044 article-title: Antimicrobial resistance and predisposing factors associated with catheter-associated UTI caused by uropathogens exhibiting multidrug-resistant patterns: a 3-year retrospective study at a tertiary Hospital in Mogadishu, Somalia. publication-title: Tropical Medicine Infectious Diseases doi: 10.3390/tropicalmed7030042 – volume: 109 start-page: 309 issue: 7 year: 2015 ident: pone.0308946.ref047 article-title: Antimicrobial resistance: a global multifaceted phenomenon. publication-title: Pathogens and global health. doi: 10.1179/2047773215Y.0000000030 – volume: 12 start-page: e201 issue: 2 year: 2024 ident: pone.0308946.ref005 article-title: The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis publication-title: The Lancet Global Health doi: 10.1016/S2214-109X(23)00539-9 – volume: 15 start-page: 895 year: 2022 ident: pone.0308946.ref036 article-title: Emergence of high prevalence of extended-spectrum beta-lactamase and carbapenemase producing Acinetobacter species and pseudomonas aeruginosa among hospitalized patients at Dessie comprehensive specialized Hospital, North-East Ethiopia. publication-title: Infection and Drug Resistance doi: 10.2147/IDR.S358116 – start-page: 369 year: 2013 ident: pone.0308946.ref001 article-title: Healthcare-associated infections. publication-title: Infectious disease epidemiology theory and practice – volume: 7 start-page: 100 issue: 1 year: 2021 ident: pone.0308946.ref031 article-title: Bacterial isolates and their antibiotic sensitivity pattern of surgical site infections among the surgical ward patients of Asella Referral and Teaching Hospital publication-title: Future Journal of Pharmaceutical Sciences doi: 10.1186/s43094-021-00255-x – volume: 2021 start-page: 1 year: 2021 ident: pone.0308946.ref023 article-title: Bacterial profile, antimicrobial susceptibility pattern, and associated factors of community-and hospital-acquired urinary tract infection at Dessie Referral Hospital, Dessie, Northeast Ethiopia. publication-title: International journal of microbiology doi: 10.1155/2021/5553356 – volume: 74 start-page: 1825 issue: 7 year: 2019 ident: pone.0308946.ref051 article-title: Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology publication-title: Journal of Antimicrobial Chemotherapy doi: 10.1093/jac/dkz147 – volume: 49 start-page: 119 year: 2016 ident: pone.0308946.ref043 article-title: Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis publication-title: International Journal of Infectious Diseases doi: 10.1016/j.ijid.2016.06.014 – year: 2023 ident: pone.0308946.ref025 publication-title: High incidence of catheter-associated urinary tract infections and related antibiotic resistance in two hospitals of different geographic regions of Sierra Leone: a prospective cohort study – volume-title: Drug-Resistant Infections: A Threat to Our Economic Future year: 2017 ident: pone.0308946.ref006 doi: 10.1596/26707 – volume: 13 start-page: 1 issue: 1 year: 2024 ident: pone.0308946.ref026 article-title: Incidence of catheter-associated urinary tract infections by Gram-negative bacilli and their ESBL and carbapenemase production in specialized hospitals of Bahir Dar, northwest Ethiopia. publication-title: Antimicrobial Resistance & Infection Control. doi: 10.1186/s13756-024-01368-7 – volume: 14 start-page: 1 issue: 12 year: 2019 ident: pone.0308946.ref028 article-title: Magnitude of surgical site infection and its associated factors among patients who underwent a surgical procedure at Wolaita Sodo University Teaching and Referral Hospital, South Ethiopia. publication-title: PLoS One. – volume: 20 start-page: 1 year: 2021 ident: pone.0308946.ref033 article-title: Bacterial profile and antimicrobial susceptibility patterns of isolates among patients diagnosed with surgical site infection at a tertiary teaching hospital in Ethiopia: a prospective cohort study publication-title: Annals of Clinical Microbiology and Antimicrobials doi: 10.1186/s12941-021-00440-z – volume-title: Open Forum Infectious Diseases year: 2023 ident: pone.0308946.ref042 |
| SSID | ssj0053866 |
| Score | 2.5124998 |
| SecondaryResourceType | review_article |
| Snippet | Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading infectious... Background Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading... BackgroundAntimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa, the leading... Background Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to the healthcare systems. Pseudomonas aeruginosa , the leading... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0308946 |
| SubjectTerms | Amikacin Aminoglycosides Amoxicillin Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Antimicrobial agents Antimicrobial resistance Bacteria Bacterial diseases Bacterial infections Biology and Life Sciences Ceftazidime Ceftriaxone Citation management software Clavulanic acid Clinical isolates Control systems Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Drug resistance Drug resistance in microorganisms Drug Resistance, Bacterial Ethiopia - epidemiology Gentamicin Health aspects Health care Heterogeneity Hospitals Humans Infection Infectious diseases Information management Medical Subject Headings-MeSH Medicine and Health Sciences Meropenem Meta-analysis Microbial Sensitivity Tests Multidrug resistance Nosocomial infections Pathogens Penicillin People and Places Physical Sciences Pseudomonas aeruginosa Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - isolation & purification Pseudomonas Infections - drug therapy Pseudomonas Infections - epidemiology Pseudomonas Infections - microbiology Public health Research and Analysis Methods Search engines Streptococcus infections Subgroups Sulfamethoxazole Surgical site infections Surveillance systems Systematic review Trimethoprim Trimethoprim-sulfamethoxazole Urogenital system |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hnLggyquGAgtCAg5ubc_6sdwCoipIPAQU9Wbty62l1o7q5CfxP5mx1yZGlcqBW5SdjZL5ZibfyLPfMvYigirVRtjQAFShyCEJZWpdSNwbi1-m0v7-lE-fs6Nj8fEkPdm66otmwgZ54MFxB3kBRtpcZTZVAvJISyOyymHrIJVSUU-NIhmNzdRQgzGLs8wflIM8PvC47K_axu2TQoskwrv1R9Tr9U9VebE6b7urKOffk5Nbf0WHt9ktzyH5cvjuO-yGa-6wHZ-lHX_lpaRf32W_ls26vqh7sSXcga010UW04v6ubt5W_GvnNrbFcFQdV-5yc1o3baf4eGaS1xiexEg5HUXhZ9PAWKg8tM7ycaar6fAlpyH6dlWrN3zJ_0hF8-GYDFeN5RdurULlBVHusePD9z_eHYX-YobQZBLWoXASO0VTpJEwSgN2iAaczR2SAW1Sp6sCwSJZFymKCCwyjNiauNCRFkjQLMB9tmgQil3GM4H7NSQuj7UArQusINJi0S2ENQlAwGBEqTRetZwuzzgv-0dxOXYvg9NLwrb02AYsnHatBtWOa-zfUgBMtqS53b-BkVj6SCyvi8SAPaXwKQccpspRLotIZEi88jRgz3sL0t1oaLDnVG26rvzw5ec_GH3_NjN66Y2qFt1hlD9Mgb-JgmdmuTezxOphZsu7FOyjV7oS0Uywh0RijjvHBLh6-dm0TB9Kw3qNazeDDeYfcteAPRjyZfIsSAQhARGwYpZJM9fPV5r6rJc9j2NAfprlD_8HWI_YzQTpKT0diGGPLdaXG_cY6eVaP-kryW8SYXy2 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Zb9QwELZgeUFCiJajgQIGIQEPbpPYOcwLWhBVQeIQUNS3yFe2kdpk2ez-JP4nM4mTNqgC3lbxOFp7jny2Zz4T8izkZaKNsMxwXjKR8ZjJxDqG2BuCX6qS7v6Uj5_SwyPx4Tg59hturU-rHGJiF6htY3CPfJ-HMgZsC4Dh9fInw1uj8HTVX6FxlVyLAKqgVWfH44ILfDlNfbkcz6J9r529ZVO7PeRpkQh7L3yOOtb-MTbPlqdNexnw_DN_8sIH6eAWuemRJJ33qt8iV1y9TW7023C0ry7aJlved1v6whNMv7xNfs3rdXVWdRRM8AZYcCOIBCnqb_CmTUm_tG5jGxi1aqlyq82iqptW0aGSklZgtIhTKRao0JMxjYwpr3Bn6ZDpVbfwk2JqfbOs1Cs6p-cE0rQvnqGqtvTMrRVTniblDjk6ePf97SHz1zUwk0q-ZsJJWD-aPAmFURr0JQx3NnMAEbRJnC5zmygke5EiD7kF3BFZE-U61AJgm-X8LpnVoJodQlMB_TWPXRZpwbXOIa5IC6E4F9bEnAeED1orjOcyxys1TovugC6DNU2vhAJ1XXhdB4SNvZY9l8c_5N-gQYyyyMTdPWhWi8I7dpHl3EibqRQGJ3gWamlEWjpY2kqlVKgC8hjNqej1MMaTYp6HIgU4liUBedpJIBtHjek-C7Vp2-L95x__IfTt60TouRcqG5gOo3yJBYwJjWciuTuRhJhiJs07aPzDrLTFufdBz8EhLm9-MjbjSzGFr3bNppcBfwREG5B7vf-MM8slKCHmIiD5xLMmUz9tqauTjgw9ijig1jS7__f_9YBcjwGO4mlAxHfJbL3auIcAJ9f6URczfgNol3jJ priority: 102 providerName: ProQuest |
| Title | Antimicrobial resistance profile of Pseudomonas aeruginosa clinical isolates from healthcare-associated infections in Ethiopia: A systematic review and meta-analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39137234 https://www.proquest.com/docview/3092758835 https://www.proquest.com/docview/3092866710 https://pubmed.ncbi.nlm.nih.gov/PMC11321567 https://doaj.org/article/783c9d7a6d5a4370b9c46fe0269aaa0a http://dx.doi.org/10.1371/journal.pone.0308946 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLa27oUXxLgtMIpBSMBDqiR24gQJoW5aGUgb06Cob5Fv6SJ1SWlaCX4Q_5PjxAkEFQEvUVUfR8q55Tux_R2EnnkkC4WkypWEZC5lJHCTUGnXYG9IfhEP6_4pZ-fR6ZS-n4WzHdT2bLUKrLaWdqaf1HS1GH398u0NBPzrumsD89tJo2VZ6JHhX0lotIv24N0UGD8_o926AkR3vXppUIsbBR6xh-n-dJfey6rm9O8y92C5KKttsPT33ZW_vK4mt9BNizPxuHGMfbSji9to30ZyhV9YuumXd9D3cbHOr_OakAlmQPltICVIYdvPG5cZvqj0RpXgsrzCXK8287woK47bc5U4Bxc2qBWb4yr4qttU5nJrfq1wu--rqOAnNhvty2XOX-Ex_kknjZujNJgXCl_rNXe5JU25i6aTk0_Hp65t3uDKKCFrl-oEqkkZhx6VXBCoIiXRimkADEKGWmSxCrmhfklo7BEFKMRX0o-FJyiAOEXIPTQowBQHCEcU5gsSaOYLSoSIIcskChJzTJUMCHEQaa2USstsbhpsLNJ6uY5BhdMoPTW2Ta1tHeR2s5YNs8df5I-MA3Syhpe7_qNczVMb5imLiUwU4xE8HCXME4mkUaah0E045x530GPjPmljhy67pOPYoxGAMxY66GktYbg5CrP5Z843VZW--_D5H4Q-XvaEnluhrAR1SG4PXMAzGefpSR72JCHDyN7wgXH2VitVCtYMoM4E8A4z2wDYPvykGzY3NRv6Cl1uGhmIRcC3DrrfxEunWZKAEQJCHRT3Iqmn-v5IkV_V1Oi-TwDDRuzBfxr3IboRAFo1iwU-OUSD9WqjHwHaXIsh2mUzBtf42DfXydsh2js6Ob-4HNbfb4Z1gvkBa_2G4g |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLam7gEkhNi4LDCYQSDgIVsSOzekCXWwqWVbmXZBewuO7XaVtqQ0rRA_iL_Bb-OcxMkWNAEve6vqk5vP7bN9LoS8dNjQTyVXtmRsaPOQeXbsK20j9gbjFwi_7J-yPwh6J_zTqX-6QH7VuTAYVlnbxNJQq1ziHvkGc2IPsC0AhveTbzZ2jcLT1bqFhjCtFdRmWWLMJHbs6h_fYQlXbPY_Ar9fed7O9vGHnm26DNgyiNnM5jqGZY-MfIdLkcJjuGRahRo8Wyp9nQ4j5QusURLzyGEK3KWrpBulTsrhUQo3RMEFLALsYKBVi1vbg4PD2heANQkCk7DHQnfDyMf6JM_0OlaKiRF4X3GIZd-Axjt0Jud5cR30_TOC84pL3LlH7hosS7uV8C2RBZ0tkzvVRiCt8puWyZKxHgV9Y0pcv71PfnZhFi_GZREouAMs-RHGAhU1PcRpPqQHhZ6rHOZdFFTo6Xw0zvJC0DqXk45BbRApU0yRoWdNIJstjMhpRetYs6yAnxSD-_PJWLyjXXpZwppW6TtUZIpe6JmwhSnU8oCc3AgrH5JOBqxZITTgcH3KPB26KWdpGoFlixU4g4gr6TFmEVZzLZGmmjo29ThPyiPCEFZVFRMS5HVieG0Ru7lqUlUT-Qf9FgpEQ4u1wMs_8ukoMaYlCSMmYxWKAD6Os9BJY8mDoYbFdSyEcIRF1lCckooPjUVLupHDAwCEoW-RFyUF1gPJMOBoJOZFkfQ_f_kPoqPDFtFrQzTMYTqkMEke8E0oPC3K1RYlWDXZGl5B4a9npUgu9R-urBXi-uHnzTDeFIMIM53PKxrQR8DUFnlU6U8zsywGJniMWyRqaVZr6tsj2fisLMfuugxwcxA-_vt7rZFbveP9vWSvP9h9Qm57AI7xbMJlq6Qzm871UwC3s_SZsSCUfL1po_UbiO67EQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamISEkhNi4LDCYQSDgIWsSOzckhAqjWhmMCRjqW3Bsp4u0JaVphfhB_Al-HeckTragCXjZW1Ufp43P7bN9LoQ8cljmp5IrWzKW2Txknh37StuIvcH4BcKv-6e83w92D_nbiT9ZIb_aXBgMq2xtYm2oVSnxjHzAnNgDbAuAYZCZsIiDndHL2TcbO0jhTWvbTqMRkT394zts36oX4x3g9WPPG735_HrXNh0GbBnEbGFzHcOWR0a-w6VI4Se4ZFqFGrxaKn2dZpHyBdYniXnkMAWu0lXSjVIn5YA0FB6Ggvm_FDJw66BL4aTb7IEdCQKTqsdCd2AkY3tWFnoba8TECLnPuMK6Y0DnF1Znx2V1Huj9M3bzjDMcXSfXDIqlw0bs1siKLtbJ1eYIkDaZTetkzdiNij41xa2f3SA_h8UiP8nr8k_wBNjsI4AFKmq6h9MyoweVXqoSVllUVOj5cpoXZSVom8VJc1AYxMgUk2PoURfCZgsjbFrRNsqsqOAjxbD-cpaL53RIT4tX0yZxh4pC0RO9ELYwJVpuksMLYeQtsloAazYIDTjMT5mnQzflLE0jsGmxAjcQcSU9xizCWq4l0tRRx3Yex0l9ORjCfqphQoK8TgyvLWJ3s2ZNHZF_0L9CgehosQp4_UU5nybGqCRhxGSsQhHAy3EWOmkseZBp2FbHQghHWGQLxSlp-NDZsmQYOTwAKBj6FnlYU2AlkAJ1aiqWVZWMP3z5D6JPH3tETwxRVsJySGHSO-CdUHh6lJs9SrBnsje8gcLfrkqVnGo-zGwV4vzhB90wPhTDBwtdLhsa0EdA0xa53ehPt7IsBiZ4jFsk6mlWb-n7I0V-VBdid10GiDkI7_z9f22Ry2Cqknfj_b275IoHqBgvJVy2SVYX86W-B6h2kd6vzQclXy_aXv0Ggqi4rQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antimicrobial+resistance+profile+of+Pseudomonas+aeruginosa+clinical+isolates+from+healthcare-associated+infections+in+Ethiopia%3A+A+systematic+review+and+meta-analysis&rft.jtitle=PloS+one&rft.au=Asmare%2C+Zelalem&rft.au=Reta%2C+Melese+Abate&rft.au=Gashaw%2C+Yalewayker&rft.au=Getachew%2C+Ermias&rft.date=2024-08-13&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=19&rft.issue=8&rft.spage=e0308946&rft_id=info:doi/10.1371%2Fjournal.pone.0308946&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0308946 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |